Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy

Stefano Palomba, Francesco Orio, Tiziana Russo, Annamaria Colao, Gaetano Lombardi, Fulvio Zullo

Research output: Contribution to journalArticlepeer-review

Abstract

Low-dose alendronate is as effective as standard-dose alendronate, and its effects continue after drug withdrawal in postmenopausal osteoporotic women who are being treated with estrogen.

Original languageEnglish
Pages (from-to)476-478
Number of pages3
JournalFertility and Sterility
Volume81
Issue number2
DOIs
Publication statusPublished - Feb 2004

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy'. Together they form a unique fingerprint.

Cite this